Your session is about to expire
← Back to Search
MR Fingerprinting for Mammogram
N/A
Waitlist Available
Led By Cherie Kuzmiak, DO,FACR,FSBI
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during mri, approximately 1 hour
Awards & highlights
Study Summary
This study is evaluating whether a new MRI technique may help detect breast cancer earlier.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during mri, approximately 1 hour
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during mri, approximately 1 hour
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Ratio of Intensity Score of Normal Breast Tissue for Left Breast Tissue Compared to Right for T1 Imaging Sequence
Ratio of Intensity Score of Normal Breast Tissue for Left Breast Tissue Compared to Right for T2 Imaging Sequence
Ratio of Intensity Score of Normal Breast Tissue for Left Breast Tissue Compared to Right for the Investigational (MRF) Imaging Sequence
Trial Design
1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment1 Intervention
All participants will receive the investigational MR Fingerprinting sequence.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MR Fingerprinting
2019
N/A
~70
Find a Location
Who is running the clinical trial?
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,305 Total Patients Enrolled
Cherie Kuzmiak, DO,FACR,FSBIPrincipal InvestigatorUNC Chapel Hill
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger